Pfizer's first acute migraine treatment recommended by NICE
The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).
Stay updated with breaking news from Toby Cousens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).
The drug, sold by Covid jab maker Pfizer has previously been endorsed by reality star and migraine sufferer Khloe Kardashian and is now set to benefit 13,000 Brits living with acute migraines.
The regulator said its approval of groundbreaking Rimegepant marks a 'step-change in treatment' for the 'invisible disability that affects all aspects of life'
{"desktop":[{"injectionEnabled":false,"componentType":"gpt","targeting":{"index":-1,"hivis":"n"},"referenceNode":"header","hideOnSensitiveArticle":true,"hideOnFirstPageView":true,"relativePos":"after","name":"div-gpt-ad-oop-slot","isOOP":true,"type":"outOfPage"},{"componentType":"gpt","targeting":{"index":-2,"hivis":"n"},"referenceNode":&...
Rimegepant could soon be an option on the NHS for 145,000 patients where previous treatments have failed.